Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Clinical trial NCT07384897 · RECRUITING

Trial details

NCT number: NCT07384897
Sponsor: Université Catholique de Louvain
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer (Diagnosis)Sarcoidosis Chronic Obstructive Pulmonary Disease Immunotherapy Resistance Immune Dysregulation

Start date: 2025-02-17
Primary completion: 2030-12-01
Enrollment: 425

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.